4.3
[]. Ghosh S, et al. Oral delivery of ,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. Basic Clin Pharmacol Toxicol. 008 May;0(5):453-8.
[]. Dennis B Pacardo, et al. A dual wavelength-activatable gold nanorod complex for synergistic cancer treatment. Nanoscale. 05 Jul 8;7(8):096-03.
[3]. J Izdebski, et al. Reinvestigation of the reactions of carbodiimides with alkoxycarbonylamino acid symmetrical anhydrides. Isolation of two N-acylureas. Int J Pept Protein Res. 994 Feb;43():84-9.
[4]. L Mark Hall, et al. Development of Ecom?? and retention index models for nontargeted metabolomics: identification of ,3-dicyclohexylurea in human serum by HPLC/mass spectrometry. J Chem Inf Model. 0 May 5;5(5):-37.
[5]. Ruchi Dangi, et al. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles. J Microencapsul. 04;3(5):479-87.
H30-H35-H39-H335
P6-P30+P35-P304+P340